GWS
MRK icon

Greykasell Wealth Strategies’s Merck MRK Stock Holding History

Greykasell Wealth Strategies’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.3K Hold
251
– – 0.01% 267
2026
Q1 		$30.2K Buy
+251
New +$29K 0.01% 292
2025
Q4 		– Sell
-40
Closed -$3.36K – 499
2025
Q3 		$3.36K Hold
40
– – ﹤0.01% 354
2025
Q2 		$3.17K Hold
40
– – ﹤0.01% 293
2025
Q1 		$3.59K Buy
+40
New +$3.73K ﹤0.01% 316

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Greykasell Wealth Strategies's MRK Position: Q2 2026 in Review

Greykasell Wealth Strategies held its Merck (MRK) position steady in Q2 2026 at 251 shares worth $32.3K. The position accounts for 0.01% of the portfolio, ranked #267.

Greykasell Wealth Strategies first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Greykasell Wealth Strategies held 251 shares of Merck worth $32.3K as of Q2 2026.
  • Greykasell Wealth Strategies left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.01% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #267 holding.
  • Greykasell Wealth Strategies first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.